Versions Compared

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.

All datasets will adhere to the record structure defined for the domain, regardless of whether multiple values are collected for a variable. Guidance in this section describes conventions for maintaining the record structure defined for a domain or dataset when multiple values are collected. When conventions concepts are applicable related to TIG either Nonclinical and or Product Impact on Individual Health use cases but not both, this is denoted in the Implementation column,Implementation column.  


Metadataspec
NumRecord and Variable PopulationImplementation
1Multiple Values values for an Intervention or Event Topic Variabletopic variable

Product Impact on Individual Health only:

If multiple values are reported for an Intervention or Event general observations -observation class topic variable (e.g., --TRT in Intervention or --TERM in Events), then the applicant will split the values into multiple records or otherwise resolve the multiplicity per the data management standard operating procedures (e.g., query the data for clarification).

  • The Disposition (DS) dataset is an exception to the general rule of splitting multiple topic values into separate records. For DS, 1 record for each disposition or protocol milestone. For cases of multiple reasons for discontinuation, refer to the domain specifications for DS.
2Multiple Values values for a Findings Result Variableresult variable

If multiple result values (represented in --ORRES) are collected for a test, then multiple records will be represented for the test (represented in --TESTCD).

3

Multiple

Values for a Non-result Qualifier Variable

values for a variable with role:

  • Grouping qualifier
  • Synonym qualifier
  • Record qualifier
  • Variable qualifier

Product Impact on Individual Health only:

For multiple values The SDTM permits 1 value for each qualifier variable per record. If multiple values exist (e.g., due to a "Check all that apply" instruction on a CRF), then the value for the qualifier variable should be :

  • The variable will be populated with "MULTIPLE"
and
  • .
  • The SUPP--
should be used to store the individual responses. It is recommended that the SUPP-- QNAM value reference the corresponding standard domain variable with an appended number or letter. In some cases, the standard variable name will be shortened to meet the 8-character variable name requirement, or it may be clearer to append a meaningful character string as shown in the second Adverse Events (AE) example below, where the first 3 characters of the drug name are appended. Likewise, the QLABEL value should be similar to the standard label. The values stored in QVAL should be consistent with the controlled terminology associated with the standard variable. See Section 8.4, Relating Non-standard Variable Values to a Parent Domain, for additional guidance on maintaining appropriately unique QNAM values.The following example includes selected variables from the ae.xpt and suppae.xpt datasets for a rash with locations on the face, neck, and chest.In some cases, values for QNAM and QLABEL more specific than these may be needed.For example, a sponsor might conduct a study with 2 study drugs (e.g., open-label study of Abcicin + Xyzamin), and may require the investigator assess causality and describe action taken for each drug for the rash:In each of these examples, the use of SUPPAE should be documented in the Define-XML document and the annotated CRF. The controlled terminology used should be documented as part of value-level metadata.

If the sponsor has clearly documented that one response is of primary interest (e.g., in the CRF, protocol, or analysis plan), the standard domain variable may be populated with the primary response and SUPP-- may be used to store the secondary response(s).

For example, if Abcicin is designated as the primary study drug in the example above:Note that in the latter case, the label for standard variables AEREL and AEACN will have no indication that they pertain to Abcicin. This association must be clearly documented in the metadata and annotated CRF.
  • dataset will represent individual responses.
    • The values for QNAM will be sequential variable names, formed by appending a 1-digit integer, beginning with 1, to the original domain variable name. In cases where the standard domain variable name is already 8 characters in length, applicants will replace the last character with a digit when creating values for QNAM.
    • The value for QLABEL should be the original domain variable label for all QNAM values.
4Multiple values for a parameter

If

3Multiple Values for a Parameter

f multiple values (--VAL)  are are reported for a for a parameter in a Trial Design or Study Reference dataset (e.g., TS, OI), multiple records should be submitted for that the --PARMCD.
For example,

  • TSPARMCD = "TTYPE", TSPARM = "Trial Type", TSVAL = "EFFICACY"
  • TSPARMCD = "TTYPE", TSPARM = "Trial Type", TSVAL = "SAFETY"

When a parameter can have multiple values, the key structure for the dataset must be adequate to distinguish between the multiple records. See Section 4.1.9, Assigning Natural Keys in the Metadata.

, unless the CDISC notes for the parameter indicate otherwise (e.g., TXPARMCD=LIGHT) 

5

Single concept represented by multiple values

Nonclinical only:

4

SEND

A single concepts represented by multiple values

  • A single value may represent a combination of multiple contributing items, delimited by slashes ("/"). In
these
  • such cases, the combination is the collected value, the value analyzed, and so on—not the individual contributing items composing the value.
A noteworthy example of this scenario is combined specimens, where a single specimen may consist of material from various tissues, and the combination is examined and analyzed together during an examination. For example, a specimen consisting of testis and epididymis tissues would be included as "TESTIS/EPIDIDYMIS". Another example is the DEGENERATION/REGENERATION microscopic finding:
  • When controlled terminology applies to the variable, the combination of concepts may already exist as a controlled terminology term. If this is not the case, then a new term will be constructed by combining existing controlled terms, when possible. 
  • For example, DEGENERATION/REGENERATION is a microscopic finding that is a single concept represented by multiple values (which is different from having 2 separately collected findings of degeneration and regeneration, with 2 separate records respectively).

In these scenarios, when controlled terminology applies to the corresponding variable, the combination may already exist as a controlled terminology term; in the specimen list, this is the case for several commonly combined tissues. However, there do exist combinations that do not have a dedicated controlled term and whose rarity does not warrant creating an individual controlled term for the specific combination. In these cases, when constructing the combination term, each of the contributing items should abide by controlled terminology where possible, in order to keep the combination term consistent and easily interpretable. For example, in the TESTIS/EPIDIDYMIS case, TESTIS (the preferred term for this tissue) should be used instead of TESTES, Testis, testes, and so on, and EPIDIDYMIS should be used instead of EPIDIDYMIDES or other variations. As always, the SEND Controlled Terminology Team will evaluate feedback regarding potential new terms.

5SEND6

Multiple concepts represented by multiple valuesIn some cases, a

Nonclinical only:

  • A variable value may
comprise
  • represent multiple individual values. In
these
  • such cases, each contributing value is a separately collected or analyzed item.
This case is notably present in the directionality (--DIR), where often, multiple distinct values might be collected for a given record. In these scenarios, when
  • When controlled terminology applies to the
corresponding
  • variable, controlled terms for each
contributing
  • value
must be included as its controlled terminology submission value, and delimited from other terms by a semicolon. For example, a finding with 2 directionality values of ventral and surface would be included
  • will be represented delimited by semicolons.
  • For example, multiple distinct values may be collected for directionality (--DIR), may be collected for a result. Values may be represented using controlled terminology as "VENTRAL;SURFACE".
"

Pagenav